genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Radiation oncology
Cancer
Positive Phase II Bolsters Aura Bioscience’s Confidence in VDC-based Therapy for Ocular Melanomas
Cancer
Gene Silencing May Be the Key to Overturning Chemoresistance
News
Link between Radiation Therapy and Metabolic Disease in Childhood Cancers Exposed
Cancer
Cancer Treatment Could Be Improved by Activated Club Cells
Cancer
Destroying Cancer Cells by Enhancing Radiation Therapy
Industry News
Pluristem, Sosei Set Up in Japan to Commercialize Cell Therapy for CLI
News
Harvard’s Wyss Institute, Charité Partner on Tissue Engineering and Regeneration
Resources
Honing In on Chemoresistance Pathways
News
Researchers Discover Gene Therapy that Protects Against Radiation Exposure
News
Blood Test Determines Radiation Exposure through Genes
Scroll Up
Scroll Up
